Tag: Chemotherapy
Subsequent Breast Cancer Risk Higher for Child Cancer Survivors Receiving Doxorubicin
More than twofold increase in risk seen for those treated with ≥200 mg/m² cumulative doxorubicin versus no doxorubicin
Diet, Exercise Intervention May Aid Chemotherapy Outcomes in Breast Cancer
Although relative dose intensity similar, pathologic complete response higher with intervention
Fewer Complications Seen With Vitamin C, D Supplementation in AML
Overall survival did not differ, but significant interaction found between supplementation and NPM1 with survival
Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
Risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia elevated, but risks lower in recent years
Atezolizumab Monotherapy Beneficial for NSCLC Ineligible for Platinum-Based Chemo
First-line atezolizumab monotherapy is associated with improved overall survival compared with single-agent chemotherapy
Findings of IDEA Collaboration Have Influenced Prescribing Patterns
Significant increasing trend seen for use of three months of adjuvant chemotherapy for resected stage III colon cancer
Aerobic Exercise Cuts Chemotherapy-Induced Peripheral Neuropathy Symptoms
Findings seen for women treated for ovarian cancer, with bigger improvement for those with symptoms at baseline
Chemotherapy-Induced Pseudocellulitis Described in Case Reports
Cases of true chemo-induced pseudocellulitis resembled infectious cellulitis; did not meet diagnostic criteria for known diagnoses
Overweight Tied to Better Head, Neck Cancer Outcomes After Chemoradiotherapy
Benefits seen for complete metabolic response after chemoradiotherapy, survival, and locoregional failure
ASCO: FOLFOX Noninferior to Chemoradiotherapy for Overall Survival in Rectal Cancer
Findings seen in patients with locally advanced rectal cancer who were eligible for sphincter-sparing surgery
